Targeting STAT3 Enzyme for Cancer Treatment

被引:0
|
作者
Arun, Sowmiya [1 ]
Patel, Praveen Kumar [1 ]
Lakshmanan, Kaviarasan [2 ]
Rajangopal, Kalirajan [1 ]
Swaminathan, Gomathi [1 ]
Byran, Gowramma [1 ]
机构
[1] JSS Acad Higher Educ & Res, Dept Pharmaceut Chem, JSS Coll Pharm, Nilgiris 643001, Tamil Nadu, India
[2] Satyabhama Inst Sci & Technol, Sch Pharm, Dept Pharmaceut Chem, Chennai, Tamil Nadu, India
关键词
STAT3; inhibitors; SH-2; domain; proliferation; phosphorylation; hematological malignancies; tyrosine residue; NF-KAPPA-B; SIGNAL TRANSDUCER; TRANSCRIPTION; 3; KEY REGULATOR; EXPRESSION; ACTIVATOR; COMMUNICATION; SUPPRESSOR; APOPTOSIS; REVEALS;
D O I
10.2174/0113895575254012231024062619
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A category of cytoplasmic transcription factors called STATs mediates intracellular signaling, which is frequently generated at receptors on cell surfaces and subsequently sent to the nucleus. STAT3 is a member of a responsible for a variety of human tumor forms, including lymphomas, hematological malignancies, leukemias, multiple myeloma and several solid tumor types. Numerous investigations have demonstrated constitutive STAT3 activation lead to cancer development such as breast, head and neck, lung, colorectal, ovarian, gastric, hepatocellular, and prostate cancers. It's possible to get a hold of the book here. Tumor cells undergo apoptosis when STAT3 activation is suppressed. This review highlights the STAT3 activation and inhibition which can be used for further studies.
引用
收藏
页码:1252 / 1261
页数:10
相关论文
共 50 条
  • [21] Targeting STAT3 in prostate cancer: Identification of STAT3 as a direct target of the fungal metabolite galiellalactone.
    Don-Doncow, Nicholas
    Escobar, Zilma
    Johansson, Martin
    Munoz, Eduardo
    Sterner, Olov
    Bjartell, Anders
    Hellsten, Rebecka
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [22] Targeting colon cancer with the novel STAT3 inhibitor bruceantinol
    Wei, Ning
    Li, Jun
    Fang, Cheng
    Chang, Jin
    Xirou, Vasiliki
    Syrigos, Nick K.
    Marks, Benjamin J.
    Chu, Edward
    Schmitz, John C.
    ONCOGENE, 2019, 38 (10) : 1676 - 1687
  • [23] Targeting colon cancer with the novel STAT3 inhibitor bruceantinol
    Ning Wei
    Jun Li
    Cheng Fang
    Jin Chang
    Vasiliki Xirou
    Nick K. Syrigos
    Benjamin J. Marks
    Edward Chu
    John C. Schmitz
    Oncogene, 2019, 38 : 1676 - 1687
  • [24] Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer
    Sen, Malabika
    Joyce, Sonali
    Panahandeh, Mary
    Li, Changyou
    Thomas, Sufi M.
    Maxwell, Jessica
    Wang, Lin
    Gooding, William E.
    Johnson, Daniel E.
    Grandis, Jennifer R.
    CLINICAL CANCER RESEARCH, 2012, 18 (18) : 4986 - 4996
  • [25] Targeting key transcriptional factor STAT3 in colorectal cancer
    Gayathri Chalikonda
    Hoomin Lee
    Aliya Sheik
    Yun Suk Huh
    Molecular and Cellular Biochemistry, 2021, 476 : 3219 - 3228
  • [26] Targeting key transcriptional factor STAT3 in colorectal cancer
    Chalikonda, Gayathri
    Lee, Hoomin
    Sheik, Aliya
    Huh, Yun Suk
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2021, 476 (09) : 3219 - 3228
  • [27] Targeting transcription factor STAT3 for cancer prevention and therapy
    Chai, Edna Zhi Pei
    Shanmugam, Muthu K.
    Arfuso, Frank
    Dharmarajan, Arunasalam
    Wang, Chao
    Kumar, Alan Prem
    Samy, Ramar Perumal
    Lim, Lina H. K.
    Wang, Lingzhi
    Goh, Boon Cher
    Ahn, Kwang Seok
    Hui, Kam Man
    Sethi, Gautam
    PHARMACOLOGY & THERAPEUTICS, 2016, 162 : 86 - 97
  • [28] Small molecule targeting Stat3 activity in breast cancer
    不详
    CANCER BIOLOGY & THERAPY, 2005, 4 (04) : II - III
  • [29] Eriocalyxin B Inhibits STAT3 Signaling by Covalently Targeting STAT3 and Blocking Phosphorylation and Activation of STAT3
    Yu, Xiaokui
    He, Li
    Cao, Peng
    Yu, Qiang
    PLOS ONE, 2015, 10 (05):
  • [30] Novel STAT3 Inhibitors Targeting STAT3 Dimerization by Binding to the STAT3 SH2 Domain
    Hua, Yaping
    Yuan, Xing
    Shen, Yun-heng
    Wang, Jinxin
    Azeem, Waqas
    Yang, Shuo
    Gade, Alexandra
    Lellahi, Seyed Mohammad
    oyan, Anne Margrete
    Ke, Xisong
    Zhang, Wei-dong
    Kalland, Karl-Henning
    FRONTIERS IN PHARMACOLOGY, 2022, 13